Fate of antibiotics in activated sludge followed by ultrafiltration (CAS-UF) and in a membrane bioreactor (MBR).
暂无分享,去创建一个
Asher Brenner | Rami Messalem | Avi Aharoni | Mathias Ernst | M. Jekel | A. Brenner | Martin Jekel | H. Cikurel | Eyal Sahar | Haim Cikurel | Manuel Godehardt | M. Godehardt | M. Ernst | A. Aharoni | R. Messalem | E. Sahar | Eyal Sahar | Manuel Godehardt
[1] Herman Goossens,et al. European Surveillance of Antimicrobial Consumption (ESAC): outpatient antibiotic use in Europe. , 2011, The Journal of antimicrobial chemotherapy.
[2] T. Ternes. Occurrence of drugs in German sewage treatment plants and rivers 1 Dedicated to Professor Dr. Klaus , 1998 .
[3] A. Schäfer,et al. Critical risk points of nanofiltration and reverse osmosis processes in water recycling applications , 2006 .
[4] E. Thurman,et al. Pharmaceuticals, hormones, and other organic wastewater contaminants in U.S. streams, 1999-2000: a national reconnaissance. , 2002 .
[5] M. Jekel,et al. COMPARISON OF TWO TREATMENTS FOR THE REMOVAL OF ORGANIC MICRO-POLLUTANTS: CONVENTIONAL ACTIVATED SLUDGE (CAS) FOLLOWED BY ULTRAFILTRATION (UF) VS. MEMBRANE BIOREACTOR (MBR) , 2011 .
[6] N Kreuzinger,et al. Comparison of the behaviour of selected micropollutants in a membrane bioreactor and a conventional wastewater treatment plant. , 2004, Water science and technology : a journal of the International Association on Water Pollution Research.
[7] H Kroiss,et al. Relevance of the sludge retention time (SRT) as design criteria for wastewater treatment plants for the removal of endocrine disruptors and pharmaceuticals from wastewater. , 2004, Water science and technology : a journal of the International Association on Water Pollution Research.
[8] D. D. Mishra,et al. Studies on the correlation between structure and adsorption of sulfonamide compounds , 2000 .
[9] T. Heberer,et al. From municipal sewage to drinking water: fate and removal of pharmaceutical residues in the aquatic environment in urban areas. , 2002, Water science and technology : a journal of the International Association on Water Pollution Research.
[10] Terri Damstra,et al. International Programme on Chemical Safety Global Assessment: The State-of-the-Science of Endocrine Disruptors , 2002 .
[11] T Wintgens,et al. Removal of hormones and pharmaceuticals in the Advanced Water Recycling Demonstration Plant in Queensland, Australia. , 2004, Water science and technology : a journal of the International Association on Water Pollution Research.
[12] N. Paxéus. Removal of selected non-steroidal anti-inflammatory drugs (NSAIDs), gemfibrozil, carbamazepine, beta-blockers, trimethoprim and triclosan in conventional wastewater treatment plants in five EU countries and their discharge to the aquatic environment. , 2004, Water science and technology : a journal of the International Association on Water Pollution Research.
[13] Robert C. Andrews,et al. Membrane adsorption of endocrine disrupting compounds and pharmaceutically active compounds , 2007 .
[14] Mira Petrovic,et al. Analysis of pharmaceuticals in wastewater and removal using a membrane bioreactor , 2006, Analytical and bioanalytical chemistry.
[15] R M Stuetz,et al. Fate of antibiotics during municipal water recycling treatment processes. , 2010, Water research.
[16] T. Ternes,et al. Assessment of the importance of sorption for steroid estrogens removal during activated sludge treatment. , 2005, Chemosphere.
[17] T. Ternes,et al. Pharmaceuticals and personal care products in the environment: agents of subtle change? , 1999, Environmental health perspectives.
[18] Christian Zwiener,et al. Oxidative treatment of pharmaceuticals in water , 2000 .
[19] Adriano Joss,et al. Fate of sulfonamides, macrolides, and trimethoprim in different wastewater treatment technologies. , 2007, The Science of the total environment.
[20] Måns Ehrenberg,et al. The mechanism of action of macrolides, lincosamides and streptogramin B reveals the nascent peptide exit path in the ribosome. , 2003, Journal of molecular biology.